ProPhase Labs, Inc. (PRPH) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 24 PAGES: 32

More Info
									           ProPhase Labs, Inc. (PRPH) - Financial and Strategic SWOT Analysis
                                         Review
        Reference Code: GDPH124335FSA                                                                                         Publication Date: AUG 2012

          621 Shady Retreat Rd                               Phone              +1 215 3450919                  Revenue          17.5 (million USD)
          Doylestown, PA                                     Fax                +1 215 3455920                  Net Profit       -2.71 (million USD)
          18901                                              Website            www.prophaselabs.com            Employees        49
                                                                                                                                 Pharmaceuticals           &
          United States                                      Exchange           PRPH [NASDAQ]                   Industry
                                                                                                                                 Healthcare

       Company Overview
       ProPhase Labs. Inc. (ProPhase Labs), formerly The Quigley Corporation, is a publicly held pharmaceutical company. It is focused
       on research, development, production and distribution of homeopathic and health products and commercialization of natural base
       health products; over-the-counter (OTC) cold remedy and consumer products; and other supplements and cosmeceuticals. It also
       offers contract manufacturing services. The company's product pipeline consists of Cold-EEZE and Kids- EEZE and Organix
       cough/cold drops indicated for the treatment of common cold. It owns a manufacturing facility in Lebanon, Pennsylvania and has
       ownership rights under a joint venture in Phusion Laboratories LLC.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      ProPhase Labs, Inc., SWOT Analysis
         Ted Karkus                          Chairman                                 Strengths                              Weaknesses
         Mark Burnett                        Director
                                                                                                                             Concentration of Revenues
         James McCubbin                      Director                                 Sturdy R&D Activities
                                                                                                                             Weak Financial Position
         Mark Leventhal                      Director
         Louis Gleckel                       Director
        Source: Annual Report, Company Website, Primary and Secondary
                                                                                      Opportunities                          Threats
        Research, GlobalData
                                                                                      Changing Demographics                  Uncertain R&D Outcomes
       Share Data
                                                                                                                             Seasonality of Operations
         ProPhase Labs, Inc.
        Share Price (USD) as on 10-Aug-                                  1.04
        2012                                                                         Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        EPS (USD)                                                       -0.18
        Market Cap (million USD)                                           15
        Enterprise Value (million USD)                                      9
        Shares Outstanding (million)                                       15
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Aug 13, 2012         ProPhase Labs Reports Revenue Of $1.9m In
                                                                                                           Q2 2012
                                                                                      May 10, 2012         ProPhase Labs Reports Net Sales Of $6m In
                                                                                                           Q1 2012
                                                                                      Mar 06, 2012         ProPhase Labs Reports Net Sales Of $7.5m In
                                                                                                           Q4 2011
                                                                                      Nov 17, 2011         ProPhase Labs's Cold-EEZE Cold Remedy
                                                                                                           Receives Parent Tested Parent Approved Seal
                                                                                                           Of Approval
       Source: Annual Report, Company Website, Primary and Secondary                 Source: Annual Report, Company Website, Primary and Secondary Research,
       Research, GlobalData                                                          GlobalData




ProPhase Labs, Inc. (PRPH) - Financial and Strategic SWOT                                                                     Reference Code: GDPH124335FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       ProPhase Labs, Inc. - Key Facts ........................................................................................................................................................ 4
       ProPhase Labs, Inc. - Key Employees ............................................................................................................................................... 5
       ProPhase Labs, Inc. - Key Employee Biographies ............................................................................................................................. 6
       ProPhase Labs, Inc. - Major Products and Services .......................................................................................................................... 7
       ProPhase Labs, Inc. - History ............................................................................................................................................................. 8
       ProPhase Labs, Inc. - Company Statement ....................................................................................................................................... 9
       ProPhase Labs, Inc. - Locations And Subsidiaries ........................................................................................................................... 10
          Head Office ................................................................................................................................................................................... 10
          Other Locations & Subsidiaries ..................................................................................................................................................... 10
       Section 2 – Company Analysis ......................................................................................................................................................... 11
       ProPhase Labs, Inc. - Business Description..................................................................................................................................... 11
       ProPhase Labs, Inc. - Corporate Strategy ........................................................................................................................................ 12
       ProPhase Labs, Inc. - SWOT Analysis ............................................................................................................................................. 13
          SWOT Analysis - Overview........................................................................................................................................................... 13
          ProPhase Labs, Inc. - Strengths ................................................................................................................................................... 13
             Strength - Sturdy R&D Activities ............................................................................................................................................... 13
          ProPhase Labs, Inc. - Weaknesses .............................................................................................................................................. 13
             Weakness - Concentration of Revenues ................................................................................................................................... 13
             Weakness - Weak Financial Position ........................................................................................................................................ 13
             Weakness - Dependence on Third Parties ................................................................................................................................ 14
          ProPhase Labs, Inc. - Opportunities ............................................................................................................................................. 14
             Opportunity - Cha
								
To top